We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

Novel Patch-Based Ebolavirus Diagnostic to Help Quickly Identify and Treat Infected Individuals

By LabMedica International staff writers
Posted on 22 Aug 2023
Print article
Image: The SatioDot dried blood spot collection patch (Photo courtesy of Satio)
Image: The SatioDot dried blood spot collection patch (Photo courtesy of Satio)

A groundbreaking diagnostic that combines a patch-based blood collection device with a sensitive and rapid immunoassay for ebolavirus into a single device will allow community health workers to quickly identify and treat infected individuals in remote settings.

The novel, single-use, rapid ebolavirus diagnostic will combine Satio, Inc.’s (Boston, MA, USA) patch-based blood collection device with an ebolavirus immunoassay from Institut Pasteur de Dakar (Dakar, Senegal). Satio is working on a suite of patch-based platforms, including SatioDot optimized for dried blood spots, and SatioDraw designed for comprehensive whole blood collection, which can cater to an extensive array of lab-based tests. These platforms employ a lancet to gather blood from the upper arm, channeling it into the patch. Satio is now accelerating the development of an integrated blood draw and diagnostic platform with the potential to extend its capabilities for identifying other critical blood-borne pathogens, such as HIV and syphilis.

Satio's groundbreaking designs, covered by patent protection, provide patients with access to simple and cost-effective blood collection options. These solutions facilitate blood extraction, reagent mixing, and the identification of an array of pathogens, all achieved through a patch affixed to the arm. In a remarkable extension, Satio's patch technology also holds the potential for the painless administration of drugs and vaccines. Consequently, this innovation holds the promise to mitigate or even eliminate the necessity for needles and medical professional intervention. By doing away with conventional fingerstick blood samples and the associated external blood sample manipulation, Satio's trailblazing innovation reduces exposure to bloodborne pathogens. Simultaneously, it offers an exceptional, budget-friendly diagnostic tool for easy deployment at the point of need, thereby advancing patient outcomes and restricting the spread of ebolavirus.

Related Links:
Satio, Inc.
Institut Pasteur de Dakar 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Hemoglobin Testing System

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.